Denosumab for prevention of fractures in postmenopausal women with osteoporosis (2009)
San Martin, Javier, McClung, Michael R, Siris, Ethel S, Eastell, Richard, Reid, Ian R, ...
BACKGROUND: Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-kappaB ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity...
Sanders, Kerrie M., Nowson, Caryl A., Kotowicz, Mark A., Briffa, Katheryn, Devine, Amanda, Reid, Ian R.
This position statement was prepared by the Working Group of the Australian and New Zealand Bone and Mineral Society and Osteoporosis Australia. The final statement was endorsed by the Endocrine...
Cundy, Tim, Hegde, Madhuri, Naot, Dorit, Chong, Belinda, King, Alan, Wallace, Robyn, ...
Idiopathic hyperphosphatasia is an autosomal recessive bone disease characterized by deformities of long bones, kyphosis and acetabular protrusion, increasing in severity as affected children pass...
Is physical activity protective against hip fracture in frail older people? (2001)
Norton, Robyn, Galgali, Geetha, Campbell, A. John, Reid, Ian R., Robinson, Elizabeth, Butler, Meg, ...
Background: there is limited evidence of a protective effect of physical activity in preventing hip fractures among older people living in institutions and in those aged 80 or over. Objective: to...
Lactoferrin – A Novel Bone Growth Factor
Naot, Dorit, Grey, Andrew, Reid, Ian R, Cornish, Jillian
Lactoferrin is an iron-binding glycoprotein that belongs to the transferrin family. It is present in breast milk, in epithelial secretions, and in the secondary granules of neutrophils. In healthy...
Lactoferrin – A Novel Bone Growth Factor
Naot, Dorit, Grey, Andrew, Reid, Ian R, Cornish, Jillian
Lactoferrin is an iron-binding glycoprotein that belongs to the transferrin family. It is present in breast milk, in epithelial secretions, and in the secondary granules of neutrophils. In healthy...
Bolland, Mark J, Barber, P Alan, Doughty, Robert N, Mason, Barbara, Horne, Anne, Ames, Ruth, ...
Objective To determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women.
Differences between the bisphosphonates for the prevention and treatment of osteoporosis
Bisphosphonates, pyrophosphate analogs which potently inhibit osteoclastic bone resorption, are now firmly established as first-line therapy for osteoporosis. Several bisphosphonates of varying...